Online Grand Rounds and Video Library

Vaccine Development for Pandemic Threats: From the Lab Bench to Clinical Trials

Objectives and Disclosures

  • Compare Covid-19 vaccine development with “normal” vaccine development using vaccine development against TB as an example
  • Interpret clinical immunology data from TB and Covid-19 clinical trials, generated by the Coler Lab team
  • Assess the steps involved in qualifying endpoint immunogenicity assays

Planners and speaker disclose they have no relevant financial relationships.

Speaker(s)

Rhea N. Coler, MSc, PhD

Date

8.19.21

Seattle Children’s is accredited by the Washington State Medical Association CME Accreditation Committee to sponsor continuing medical education for physicians.

Seattle Children’s designates this online educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 1 hour of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Videos are available for only one year after posting.

If you wish to receive Category I CME credit for viewing this Provider Grand Rounds session, please complete the evaluation form. Upon completion of the form you will receive an auto-reply email that will serve as the only confirmation of your CME credit. Please keep the email for your records.